FDA Calendar

The FDA Calendar provides a centralized view of upcoming PDUFA (Prescription Drug User Fee Act) decision dates for publicly traded biopharmaceutical companies. It helps investors and analysts track key FDA approval milestones that can significantly impact stock performance. Each entry includes the company name, ticker, drug candidate, and expected decision date.

- The PDUFA date is the target deadline for the FDA to respond to a New Drug Application (NDA) or Biologics License Application (BLA).

- It was created under the Prescription Drug User Fee Act, which funds FDA review activities through industry user fees.

- The date ensures a predictable review timeline for drug and biologic approvals.

- On the PDUFA date, the FDA may issue an approval, a Complete Response Letter, or request additional information.

- It is a key regulatory milestone tracked by investors, analysts, and drug developers.

, and